{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:29:46Z","timestamp":1762961386781,"version":"3.45.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20200151"],"award-info":[{"award-number":["BX20200151"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971464"],"award-info":[{"award-number":["81971464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM201512019"],"award-info":[{"award-number":["SZSM201512019"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15046-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:25:16Z","timestamp":1762961116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the nexus between lung cancer and rheumatoid arthritis using integrative transcriptomics and genomics"],"prefix":"10.1186","volume":"25","author":[{"given":"Heng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nini","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"15046_CR1","doi-asserted-by":"crossref","unstructured":"Seror R, Fautrel B, Lafourcade A, De-Rycke Y, Mariette X, Tubach F. OP0124\u2005RISK OF MALIGNANCIES ACROSS BIOLOGIC CLASSES IN RHEUMATOID ARTHRITIS: ANALYSIS OF A NATIONAL CLAIM DATABASE. 2020, 79(Suppl 1):81\u201382.","DOI":"10.1136\/annrheumdis-2020-eular.3687"},{"issue":"6","key":"15046_CR2","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/1759-7714.13388","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhao Q, Yuan F, Liu M. Lung cancer in patients with and without rheumatoid arthritis: a propensity score-matched survival analysis cohort study. Thorac Cancer. 2020;11(6):1406\u201313.","journal-title":"Thorac Cancer"},{"issue":"13","key":"15046_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"1","key":"15046_CR4","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170(1):Itc1\u201316.","journal-title":"Ann Intern Med"},{"issue":"1","key":"15046_CR5","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1038\/s41598-025-92150-1","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao X, Liu S, Wang Q, Wang Y, Hou S, et al. Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021. Sci Rep. 2025;15(1):10736.","journal-title":"Sci Rep"},{"issue":"9746","key":"15046_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"S DL","year":"2010","unstructured":"DL S, F W, TW H. Rheumatoid arthritis. Lancet (London England). 2010;376(9746):1094\u2013108.","journal-title":"Lancet (London England)"},{"key":"15046_CR7","doi-asserted-by":"crossref","unstructured":"Chen L, Zhao J, Meng Q. From genetic variants to therapeutic targets: insights into Understanding rheumatoid arthritis. Front Immunol. 2025;16:1556971.","DOI":"10.3389\/fimmu.2025.1556971"},{"key":"15046_CR8","doi-asserted-by":"crossref","unstructured":"Lopez-Olivo MA, Volk R, Krause KJ, Suarez-Almazor M, AB0253\u2005A REVIEW OF SMOKING CESSATION STRATEGIES AND LUNG CANCER SCREENING PRACTICES IN PATIENTS WITH RHEUMATOID ARTHRITIS. 2020, 79(Suppl 1):1426\u20131426.","DOI":"10.1136\/annrheumdis-2020-eular.4751"},{"issue":"5","key":"15046_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2014-205847","volume":"75","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Lee EB, Kaplan IV, Kwok K, Geier J, Benda B, et al. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme. Ann Rheum Dis. 2016;75(5):831\u201341.","journal-title":"Ann Rheum Dis"},{"key":"15046_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002465","author":"K Chatzidionysiou","year":"2022","unstructured":"Chatzidionysiou K, di Giuseppe D, Soderling J, Catrina A, Askling J. Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking. RMD Open. 2022. https:\/\/doi.org\/10.1136\/rmdopen-2022-002465.","journal-title":"RMD Open"},{"issue":"23","key":"15046_CR11","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"M IB","year":"2011","unstructured":"IB M. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"1","key":"15046_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12885-022-09296-8","volume":"22","author":"S Wen","year":"2022","unstructured":"Wen S, Peng W, Chen Y, Du X, Xia J, Shen B, Zhou G. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. BMC Cancer. 2022;22(1):193.","journal-title":"BMC Cancer"},{"issue":"10","key":"15046_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/omi.2024.0150","volume":"28","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S. Systems biology and machine learning identify genetic overlaps between lung cancer and gastroesophageal reflux disease. OMICS. 2024;28(10):492\u2013503.","journal-title":"OMICS"},{"issue":"2","key":"15046_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/rheumatology\/keu323","volume":"55","author":"Y A","year":"2016","unstructured":"A Y, TW H. The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. Rheumatology (Oxford). 2016;55(2):199\u2013209.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"15046_CR15","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","volume":"59","author":"LE D","year":"2020","unstructured":"LE D. The genetics of rheumatoid arthritis. Rheumatology (Oxford). 2020;59(10):2661\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"3S","key":"15046_CR16","first-page":"S49","volume":"49","author":"AS C","year":"2019","unstructured":"C AS, K T. Linking of genetic risk variants to disease-specific gene expression via multi-omics studies in rheumatoid arthritis. Semin Arthritis Rheum. 2019;49(3S):S49\u201353.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"15046_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/ard.2007.077099","volume":"67","author":"B Pg","year":"2008","unstructured":"Pg B, La C, Lf B. The MHC2TA -168A\/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis. 2008;67(7):933\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"15046_CR18","first-page":"1384","volume":"68","author":"AJFB B F-G","year":"2016","unstructured":"B F-G AJFB, JD AG, M A-L CJM, V M-T AOHC, et al. Identification of IRX1 as a risk locus for rheumatoid factor positivity in rheumatoid arthritis in a Genome-Wide association study. Arthritis Rheumatol (Hoboken NJ). 2016;68(6):1384\u201391.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"issue":"16","key":"15046_CR19","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.2015.3435","volume":"313","author":"SVDPBHBFAY W","year":"2015","unstructured":"W SVDPBHBFAY, DP T, KL SJWAY. Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response. JAMA. 2015;313(16):1645\u201356.","journal-title":"JAMA"},{"issue":"4","key":"15046_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/annrheumdis-2018-213678","volume":"78","author":"SE Y O","year":"2019","unstructured":"Y O SE, K ASYK. Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. 2019;78(4):446\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"15046_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ajhg.2016.06.019","volume":"99","author":"AS Y O","year":"2016","unstructured":"Y O AS, K I, C T, K O YK. Contribution of a Non-classical HLA Gene, HLA-DOA, to the risk of rheumatoid arthritis. Am J Hum Genet. 2016;99(2):366\u201374.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"15046_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/art.40790","volume":"71","author":"T Mustelin","year":"2019","unstructured":"Mustelin T, Bottini N, Stanford SM. The contribution of PTPN22 to rheumatic disease. Arthritis Rheumatol. 2019;71(4):486\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"15046_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3204","volume":"22","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Imani D, Bagheri-Hosseinabadi Z. PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): updated systematic review and meta\u2010analysis. J Gene Med. 2020;22(9):e3204.","journal-title":"J Gene Med"},{"issue":"10","key":"15046_CR24","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/ard.2010.144576","volume":"70","author":"PDMWHJLJDHLS X Z, PM","year":"2011","unstructured":"X Z, PM PDMWHJLJDHLS, MA V. Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Ann Rheum Dis. 2011;70(10):1793\u20137.","journal-title":"Ann Rheum Dis"},{"key":"15046_CR25","unstructured":"J L, Y J, Y L, Y J, H G, L AJ, Z H, H D, S L, Z X, et al. Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans. Arthritis Rheumatol (Hoboken NJ). 2014;66(5):1121\u201332."},{"issue":"7488","key":"15046_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"YODWGTTR C","year":"2014","unstructured":"C YODWGTTR, K I T, K O YK. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376\u201381.","journal-title":"Nature"},{"key":"15046_CR27","doi-asserted-by":"crossref","unstructured":"Emery P, Fleischmann R, Wong R, Lozenski K, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TWJ, Citera G, Perera V et al. Association between abatacept exposure levels and infection occurrence in patients with rheumatoid arthritis: post hoc analysis of the AVERT-2 study. J Rhuematol 2025:jrheum.2024\u2009\u2013\u20090498.","DOI":"10.3899\/jrheum.2024-0498"},{"key":"15046_CR28","first-page":"180","volume":"21","author":"J F","year":"2015","unstructured":"F J, G P, L W. Enrichment of genetic variants for rheumatoid arthritis within T-Cell and NK-Cell enhancer regions. Mol Med (Cambridge Mass). 2015;21:180\u20134.","journal-title":"Mol Med (Cambridge Mass)"},{"key":"15046_CR29","doi-asserted-by":"crossref","unstructured":"W AB, X T, Consortium KSEAHJBDPLJG. WTCC, Consortium et al. Y : Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nature genetics 2008, 40(10):1156\u20131159.","DOI":"10.1038\/ng.218"},{"issue":"12","key":"15046_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa073491","volume":"357","author":"P RM","year":"2007","unstructured":"RM P, EF MSLPATL, LR RBDALHKAC. TRAF1-C5 as a risk locus for rheumatoid arthritis\u2013a genomewide study. N Engl J Med. 2007;357(12):1199\u2013209.","journal-title":"N Engl J Med"},{"issue":"3","key":"15046_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/ard.2009.109447","volume":"69","author":"P NA","year":"2010","unstructured":"NA P, JP I. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis. Ann Rheum Dis. 2010;69(3):561\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"15046_CR32","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","volume":"357","author":"R EF","year":"2007","unstructured":"EF R, RM P, RR ATL, PI dB GGHTWB. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357(10):977\u201386.","journal-title":"N Engl J Med"},{"key":"15046_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roaf017","author":"M Kuwana","year":"2025","unstructured":"Kuwana M, Sugiyama N, Momohara S, Atsumi T, Takei S, Tamura N, et al. Three-year safety and effectiveness of Tofacitinib in patients with rheumatoid arthritis in Japan: final analysis of an all-case post-marketing surveillance study. Mod Rheumatol. 2025. https:\/\/doi.org\/10.1093\/mr\/roaf017.","journal-title":"Mod Rheumatol"},{"issue":"5","key":"15046_CR34","doi-asserted-by":"publisher","first-page":"e2511095","DOI":"10.1001\/jamanetworkopen.2025.11095","volume":"8","author":"T Liu","year":"2025","unstructured":"Liu T, Wang L, Zhang X, Chen L, Liu Y, Jiang Z, et al. Tocilizumab monotherapy or combined with methotrexate for rheumatoid arthritis: a randomized clinical trial. JAMA Netw Open. 2025;8(5):e2511095-2511095.","journal-title":"JAMA Netw Open"},{"key":"15046_CR35","doi-asserted-by":"crossref","unstructured":"May M, Chuah A, Lehmann N, Goodall L, Cho V, Andrews TD: Functionally constrained human proteins are less prone to mutational instability from single amino acid substitutions. Nature Communications 2025, 16(1):2492.","DOI":"10.1038\/s41467-025-57757-y"},{"key":"15046_CR36","doi-asserted-by":"crossref","unstructured":"Dai Z-T, Wang J, Zhao K, Xiang Y, Li JP, Zhang H-M, Peng Z-T, Liao XH: Integrated TCGA and GEO analysis showed that SMAD7 is an independent prognostic factor for lung adenocarcinoma. Medicine 2020, 99(44):e22861.","DOI":"10.1097\/MD.0000000000022861"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:25:17Z","timestamp":1762961117000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15046"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15046-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We strictly adhere to ethical guidelines. The trials analyzed in this study have obtained approval from the Ethics Committee of Shenzhen People\u2019s Hospital (LL-KY-2022158-01), and have been conducted in accordance with the Helsinki Declaration. Patient identifiers have not been disclosed. All participants were over 18 years of age and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1758"}}